Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.5900 (1.08%) ($5.5900 - $5.5900) on Fri. Jun. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.77% (three month average) | RSI | 76 | Latest Price | $5.5900(1.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.7% a day on average for past five trading days. | Weekly Trend | CAPR advances 11.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XAR(-3%) SKYY(20%) XLRE(12%) VFMO(-9%) SPLV(-39%) | Factors Impacting CAPR price | CAPR will decline at least -2.385% in a week (0% probabilities). IFRA(-69%) IYT(-36%) IWD(-27%) IWN(10%) IWM(18%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.385% (StdDev 4.77%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.49(1.82%) | 10 Day Moving Average | $5.16(8.33%) | 20 Day Moving Average | $4.68(19.44%) | To recent high | -2.1% | To recent low | 11.1% | Market Cap | $110m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |